Edaravone and Acetovanillone Upregulate Nrf2 and PI3K/Akt/mTOR Signaling and Prevent Cyclophosphamide Cardiotoxicity in Rats

References

• MoignetA, HasanaliZ, ZambelloR, et al. Cyclophosphamide as a first-line therapy in LGL leukemia. Leukemia. 2014;28(5):1134–1136. doi:10.1038/leu.2013.35924280867
   PubMed Web of Science ®Google Scholar
• StorkCM, SchrefflerSM. Cyclophosphamide In: WexlerP, editor. Encyclopedia of Toxicology (Third Edition). Oxford: Academic Press; 2014:1111–1113.
   Google Scholar
• IqubalA, IqubalMK, SharmaS, et al. Molecular mechanism involved in cyclophosphamide-induced cardiotoxicity: old drug with a new vision. Life Sci. 2019;218:112–131. doi:10.1016/j.lfs.2018.12.01830552952
   PubMed Web of Science ®Google Scholar
• KurauchiK, NishikawaT, MiyaharaE, OkamotoY, KawanoY. Role of metabolites of cyclophosphamide in cardiotoxicity. BMC Res Notes. 2017;10(1):406. doi:10.1186/s13104-017-2726-228807058
   PubMedGoogle Scholar
• ShanholtzC. Acute life-threatening toxicity of cancer treatment. Crit Care Clin. 2001;17(3):483–502. doi:10.1016/S0749-0704(05)70196-211529252
   PubMed Web of Science ®Google Scholar
• MorandiP, RuffiniPA, BenvenutoGM, La VecchiaL, MezzenaG, RaimondiR. Serum cardiac troponin I levels and ECG/echo monitoring in breast cancer patients undergoing high-dose (7 g/m(2)) cyclophosphamide. Bone Marrow Transplant. 2001;28(3):277–282. doi:10.1038/sj.bmt.170313211535996
   PubMed Web of Science ®Google Scholar
• BravermanAC, AntinJH, PlappertMT, CookEF, LeeRT. Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens. J Clin Oncol. 1991;9(7):1215–1223. doi:10.1200/JCO.1991.9.7.12152045862
   PubMed Web of Science ®Google Scholar
• AladailehSH, AbukhalilMH, SaghirSAM, et al. Galangin activates Nrf2 signaling and attenuates oxidative damage, inflammation, and apoptosis in a rat model of cyclophosphamide-induced hepatotoxicity. Biomolecules. 2019;9(8):346. doi:10.3390/biom9080346
   PubMed Web of Science ®Google Scholar
• ALHaithloulHAS, AlotaibiMF, Bin-JumahM, ElgebalyH, MahmoudAM. Olea europaea leaf extract up-regulates Nrf2/ARE/HO-1 signaling and attenuates cyclophosphamide-induced oxidative stress, inflammation and apoptosis in rat kidney. Biomed Pharmacother. 2019;111:676–685. doi:10.1016/j.biopha.2018.12.11230611992
   PubMed Web of Science ®Google Scholar
• KamelEM, MahmoudAM, AhmedSA, LamsabhiAM. A phytochemical and computational study on flavonoids isolated from Trifolium resupinatum L. and their novel hepatoprotective activity. Food Funct. 2016;7(4):2094–2106. doi:10.1039/C6FO00194G27053086
   PubMed Web of Science ®Google Scholar
• MahmoudAM, GermoushMO, AlotaibiMF, HusseinOE. Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother. 2017;86:297–306. doi:10.1016/j.biopha.2016.12.04728011377
   PubMed Web of Science ®Google Scholar
• MogheA, GhareS, LamoreauB, et al. Molecular mechanisms of acrolein toxicity: relevance to human disease. Toxicol Sci. 2015;143(2):242–255. doi:10.1093/toxsci/kfu23325628402
   PubMed Web of Science ®Google Scholar
• SattaS, MahmoudAM, WilkinsonFL, Yvonne AlexanderM, WhiteSJ. The role of Nrf2 in cardiovascular function and disease. Oxid Med Cell Longev. 2017;2017:9237263. doi:10.1155/2017/923726329104732
   PubMed Web of Science ®Google Scholar
• ZengJ, ZhaoH, ChenB. DJ-1/PARK7 inhibits high glucose-induced oxidative stress to prevent retinal pericyte apoptosis via the PI3K/AKT/mTOR signaling pathway. Exp Eye Res. 2019;189:107830. doi:10.1016/j.exer.2019.10783031593688
   PubMed Web of Science ®Google Scholar
• WangX, PanJ, LiuD, et al. Nicorandil alleviates apoptosis in diabetic cardiomyopathy through PI3K/Akt pathway. J Cell Mol Med. 2019;23(8):5349–5359. doi:10.1111/jcmm.1441331131539
   PubMed Web of Science ®Google Scholar
• SciarrettaS, VolpeM, SadoshimaJ. Mammalian target of rapamycin signaling in cardiac physiology and disease. Circ Res. 2014;114(3):549–564. doi:10.1161/CIRCRESAHA.114.30202224481845
   PubMed Web of Science ®Google Scholar
• SunY, GongF, YinJ, et al. Therapeutic effect of apocynin through antioxidant activity and suppression of apoptosis and inflammation after spinal cord injury. Exp Ther Med. 2017;13(3):952–960. doi:10.3892/etm.2017.409028450925
   PubMed Web of Science ®Google Scholar
• KapoorM, SharmaN, SandhirR, NehruB. Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion hippocampus injury in rat brain. Biomed Pharmacother. 2018;97:458–472. doi:10.1016/j.biopha.2017.10.12329091896
   PubMed Web of Science ®Google Scholar
• FrancisS, LaurieriN, NwokochaC, DelgodaR. Treatment of rats with apocynin has considerable inhibitory effects on arylamine N-acetyltransferase activity in the liver. Sci Rep. 2016;6:26906. doi:10.1038/srep2690627242013
   PubMed Web of Science ®Google Scholar
• GimenesR, GimenesC, RosaCM, et al. Influence of apocynin on cardiac remodeling in rats with streptozotocin-induced diabetes mellitus. Cardiovasc Diabetol. 2018;17(1):15.29343259
   PubMed Web of Science ®Google Scholar
• HouL, SunF, HuangR, SunW, ZhangD, WangQ. Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson’s disease model. Redox Biol. 2019;22:101134. doi:10.1016/j.redox.2019.10113430798073
   PubMed Web of Science ®Google Scholar
• TanYC, Abdul SattarM, AhmedaAF, et al. Apocynin and catalase prevent hypertension and kidney injury in Cyclosporine A-induced nephrotoxicity in rats. PLoS One. 2020;15(4):e0231472. doi:10.1371/journal.pone.023147232298299
   PubMed Web of Science ®Google Scholar
• HommaT, KobayashiS, SatoH, FujiiJ. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro. Exp Cell Res. 2019;384(1):111592. doi:10.1016/j.yexcr.2019.11159231479686
   PubMed Web of Science ®Google Scholar
• LinH, MaX, WangBC, et al. Edaravone ameliorates compression-induced damage in rat nucleus pulposus cells. Life Sci. 2017;189:76–83. doi:10.1016/j.lfs.2017.09.02428942283
   PubMed Web of Science ®Google Scholar
• HeF, CaoY-P, CheF-Y, YangL-H, XiaoS-H, LiuJ. Inhibitory effects of edaravone in β-amyloid-induced neurotoxicity in rats. Biomed Res Int. 2014;2014:370368. doi:10.1155/2014/37036824804216
   PubMed Web of Science ®Google Scholar
• TajimaS, BandoM, IshiiY, et al. Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice. Eur Respir J. 2008;32(5):1337–1343. doi:10.1183/09031936.0016440718614556
   PubMed Web of Science ®Google Scholar
• BasolN, AygunH, GulSS. Beneficial effects of edaravone in experimental model of amitriptyline-induced cardiotoxicity in rats. Naunyn Schmiedebergs Arch Pharmacol. 2019;392(11):1447–1453. doi:10.1007/s00210-019-01683-631273393
   PubMed Web of Science ®Google Scholar
• LiuJ, JiangY, ZhangG, LinZ, DuS. Protective effect of edaravone on blood-brain barrier by affecting NRF-2/HO-1 signaling pathway. Exp Ther Med. 2019;18(4):2437–2442.31555355
   PubMed Web of Science ®Google Scholar
• ShokrzadehM, ChabraA, NaghshvarF, AhmadiA, JafarinejhadM, Hasani-NourianY. Protective effects of melatonin against cyclophosphamide-induced oxidative lung toxicity in mice. Drug Res. 2015;65(6):281–286.
   Google Scholar
• BancroftJD, GambleM. Theory and Practice of Histological Techniques. Elsevier health sciences; 2008.
   Google Scholar
• MiharaM, UchiyamaM. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem. 1978;86(1):271–278. doi:10.1016/0003-2697(78)90342-1655387
   PubMed Web of Science ®Google Scholar
• EllmanGL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77. doi:10.1016/0003-9861(59)90090-613650640
   PubMed Web of Science ®Google Scholar
• MarklundSL. Superoxide dismutase isoenzymes in tissues and plasma from New Zealand black mice, nude mice and normal BALB/c mice. Mutat Res. 1985;148(1–2):129–134. doi:10.1016/0027-5107(85)90216-73969077
   PubMed Web of Science ®Google Scholar
• LivakKJ, SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• TrottO, OlsonAJ. AutoDock vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–461.19499576
   PubMed Web of Science ®Google Scholar
• JnoffE, AlbrechtC, BarkerJJ, et al. Binding mode and structure-activity relationships around direct inhibitors of the Nrf2-Keap1 complex. ChemMedChem. 2014;9(4):699–705. doi:10.1002/cmdc.20130052524504667
   PubMed Web of Science ®Google Scholar
• GoldbergMA, AntinJH, GuinanEC, RappeportJM. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk factor. Blood. 1986;68(5):1114–1118. doi:10.1182/blood.V68.5.1114.11143533179
   PubMed Web of Science ®Google Scholar
• OmoleJG, AyokaOA, AlabiQK, et al. Protective effect of kolaviron on cyclophosphamide-induced cardiac toxicity in rats. J Evid Based Integr Med. 2018;23:2156587218757649. doi:10.1177/215658721875764929468886
   PubMed Web of Science ®Google Scholar
• El-SheikhAA, AbdelzaherWY, GadAA, Abdel-GaberSA. Purine versus non-purine xanthine oxidase inhibitors against cyclophosphamide-induced cardiac and bone marrow toxicity in rats. Hum Exp Toxicol. 2020;39(3):249–261. doi:10.1177/096032711988341231640406
   PubMed Web of Science ®Google Scholar
• El-SawalhiMM, AhmedLA. Exploring the protective role of apocynin, a specific NADPH oxidase inhibitor, in cisplatin-induced cardiotoxicity in rats. Chem Biol Interact. 2014;207:58–66. doi:10.1016/j.cbi.2013.11.00824291008
   PubMed Web of Science ®Google Scholar
• SaleemN, PrasadA, GoswamiSK. Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat. Mol Cell Biochem. 2018;445(1):79–88. doi:10.1007/s11010-017-3253-029256115
   PubMed Web of Science ®Google Scholar
• KoohsariM, ShakiF, JahaniD. Protective effects of edaravone against methamphetamine-induced cardiotoxicity. Braz Arch Biol Technol. 2016;59. doi:10.1590/1678-4324-2016160093
   Web of Science ®Google Scholar
• Emekli-AlturfanE, AlevB, TunaliS, et al. Effects of edaravone on cardiac damage in valproic acid induced toxicity. Ann Clin Lab Sci. 2015;45(2):166–172.25887870
   PubMed Web of Science ®Google Scholar
• HassanMQ, AkhtarMS, AfzalO, et al. Edaravone and benidipine protect myocardial damage by regulating mitochondrial stress, apoptosis signalling and cardiac biomarkers against doxorubicin-induced cardiotoxicity. Clin Exp Hypertens. 2020;42(5):381–392. doi:10.1080/10641963.2019.167677031630586
   PubMed Web of Science ®Google Scholar
• SmathersRL, GalliganJJ, StewartBJ, PetersenDR. Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. Chem Biol Interact. 2011;192(1–2):107–112. doi:10.1016/j.cbi.2011.02.02121354120
   PubMed Web of Science ®Google Scholar
• MahmoudAM, Al DeraHS. 18β-glycyrrhetinic acid exerts protective effects against cyclophosphamide-induced hepatotoxicity: potential role of PPARγ and Nrf2 upregulation. Genes Nutr. 2015;10(6):41. doi:10.1007/s12263-015-0491-126386843
   PubMed Web of Science ®Google Scholar
• CaiH, HarrisonDG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840–844. doi:10.1161/01.RES.87.10.84011073878
   PubMed Web of Science ®Google Scholar
• ZorovDB, FilburnCR, KlotzLO, ZweierJL, SollottSJ. Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med. 2000;192(7):1001–1014. doi:10.1084/jem.192.7.100111015441
   PubMed Web of Science ®Google Scholar
• BrownDI, GriendlingKK. Regulation of signal transduction by reactive oxygen species in the cardiovascular system. Circ Res. 2015;116(3):531–549. doi:10.1161/CIRCRESAHA.116.30358425634975
   PubMed Web of Science ®Google Scholar
• LiS, WangW, NiuT, et al. Nrf2 deficiency exaggerates doxorubicin-induced cardiotoxicity and cardiac dysfunction. Oxid Med Cell Longev. 2014;2014:748524. doi:10.1155/2014/74852424895528
   PubMed Web of Science ®Google Scholar
• XingY, NiuT, WangW, et al. Triterpenoid dihydro-CDDO-trifluoroethyl amide protects against maladaptive cardiac remodeling and dysfunction in mice: a critical role of Nrf2. PLoS One. 2012;7(9):e44899. doi:10.1371/journal.pone.004489923028668
   PubMed Web of Science ®Google Scholar
• Abd El-TwabSM, HusseinOE, HozayenWG, Bin-JumahM, MahmoudAM. Chicoric acid prevents methotrexate-induced kidney injury by suppressing NF-kappaB/NLRP3 inflammasome activation and up-regulating Nrf2/ARE/HO-1 signaling. Inflamm Res. 2019;68(6):511–523. doi:10.1007/s00011-019-01241-z31037316
   PubMed Web of Science ®Google Scholar
• MahmoudAM, GermoushMO, Al-AnaziKM, MahmoudAH, FarahMA, AllamAA. Commiphora molmol protects against methotrexate-induced nephrotoxicity by up-regulating Nrf2/ARE/HO-1 signaling. Biomed Pharmacother. 2018;106:499–509. doi:10.1016/j.biopha.2018.06.17129990838
   PubMed Web of Science ®Google Scholar
• MahmoudAM, WilkinsonFL, McCarthyEM, et al. Endothelial microparticles prevent lipid-induced endothelial damage via Akt/eNOS signaling and reduced oxidative stress. FASEB J. 2017;31(10):4636–4648. doi:10.1096/fj.201601244RR28687612
   PubMed Web of Science ®Google Scholar
• Cruz-ÁlvarezS, Santana-MartínezR, Avila-ChávezE, et al. Apocynin protects against neurological damage induced by quinolinic acid by an increase in glutathione synthesis and Nrf2 levels. Neuroscience. 2017;350:65–74. doi:10.1016/j.neuroscience.2017.03.01128323011
   PubMed Web of Science ®Google Scholar
• ZhangM, TengCH, WuFF, et al. Edaravone attenuates traumatic brain injury through anti-inflammatory and anti-oxidative modulation. Exp Ther Med. 2019;18(1):467–474.31281440
   PubMed Web of Science ®Google Scholar
• ShouL, BeiY, SongY, et al. Nrf2 mediates the protective effect of edaravone after chlorpyrifos-induced nervous system toxicity. Environ Toxicol. 2019;34(5):626–633. doi:10.1002/tox.2272830758894
   PubMed Web of Science ®Google Scholar
• YuanW, ChangH, LiuX, WangS, LiuH, XuanH. Brazilian green propolis inhibits Ox-LDL-stimulated oxidative stress in human umbilical vein endothelial cells partly through PI3K/Akt/mTOR-mediated Nrf2/HO-1 pathway. Evid Based Complement Alternat Med. 2019;2019:5789574. doi:10.1155/2019/578957431360208
   PubMed Web of Science ®Google Scholar
• LaplanteM, SabatiniDM. mTOR signaling in growth control and disease. Cell. 2012;149(2):274–293. doi:10.1016/j.cell.2012.03.01722500797
   PubMed Web of Science ®Google Scholar
• ZhangD, ContuR, LatronicoMV, et al. MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice. J Clin Invest. 2010;120(8):2805–2816. doi:10.1172/JCI4300820644257
   PubMed Web of Science ®Google Scholar
• TamaiT, YamaguchiO, HikosoS, et al. Rheb (Ras homologue enriched in brain)-dependent mammalian target of rapamycin complex 1 (mTORC1) activation becomes indispensable for cardiac hypertrophic growth after early postnatal period. J Biol Chem. 2013;288(14):10176–10187. doi:10.1074/jbc.M112.42364023426372
   PubMed Web of Science ®Google Scholar
• SancakY, ThoreenCC, PetersonTR, et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell. 2007;25(6):903–915. doi:10.1016/j.molcel.2007.03.00317386266
   PubMed Web of Science ®Google Scholar
• ZhuW, SoonpaaMH, ChenH, et al. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway. Circulation. 2009;119(1):99–106. doi:10.1161/CIRCULATIONAHA.108.79970019103993
   PubMed Web of Science ®Google Scholar
• LeeBS, OhJ, KangSK, et al. Insulin protects cardiac myocytes from doxorubicin toxicity by Sp1-mediated transactivation of survivin. PLoS One. 2015;10(8):e0135438. doi:10.1371/journal.pone.013543826271039
   PubMed Web of Science ®Google Scholar
• AlbayrakG, SonmezPK, AkogullariD, UluerET. Cyclophosphamide inhibits PI3K/AKT/mTOR signaling pathway in mice kidneys. Proceedings. 2018;2(25):1587. doi:10.3390/proceedings2251587
   Google Scholar
• LudemannJ, VerissimoKM, DregerK, FagoA, SchneiderI, BurmesterT. Globin E is a myoglobin-related, respiratory protein highly expressed in lungfish oocytes. Sci Rep. 2019;9(1):280. doi:10.1038/s41598-018-36592-w30670817
   PubMed Web of Science ®Google Scholar
• OuL, LiX, ChenB, et al. Recombinant human cytoglobin prevents atherosclerosis by regulating lipid metabolism and oxidative stress. J Cardiovasc Pharmacol Ther. 2018;23(2):162–173. doi:10.1177/107424841772487028954528
   PubMed Web of Science ®Google Scholar
• LatinaA, ViticchieG, LenaAM, et al. DeltaNp63 targets cytoglobin to inhibit oxidative stress-induced apoptosis in keratinocytes and lung cancer. Oncogene. 2016;35(12):1493–1503. doi:10.1038/onc.2015.22226096935
   PubMed Web of Science ®Google Scholar
• ZhangS, LiX, Jourd’heuilFL, et al. Cytoglobin promotes cardiac progenitor cell survival against oxidative stress via the upregulation of the NFkappaB/iNOS signal pathway and nitric oxide production. Sci Rep. 2017;7(1):10754. doi:10.1038/s41598-017-11342-628883470
   PubMed Web of Science ®Google Scholar
• XuHW, HuangYJ, XieZY, et al. The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients. BMC Cancer. 2013;13:247. doi:10.1186/1471-2407-13-24723688241
   PubMed Web of Science ®Google Scholar
• DemirciS, DoğanA, ApdikH, et al. Cytoglobin inhibits migration through PI3K/AKT/mTOR pathway in fibroblast cells. Mol Cell Biochem. 2018;437(1):133–142. doi:10.1007/s11010-017-3101-228620820
   PubMed Web of Science ®Google Scholar